Skip to main content
IMVT
NASDAQ Life Sciences

Immunovant Posts $153M Q2 Loss, Eyes IMVT-1402 Data in H2 2026

Tom Rudovsky · Reported by Wiseek News
More coverage: Biotech Stocks · Healthcare
Sentiment info
Neutral
Importance info
7
Price
$39.74
Mkt Cap
$8.202B
52W Low
$14.32
52W High
$41.23
52W Position info
178% above low
Off High info
3.6% below high
Rel. Volume info
0.5× avg
Market data snapshot near publication time

IMVT has more than doubled off its 52-week low of $14.32.

Summary

Immunovant reported a $153.2M net loss for Q2 2026, with R&D spending of $142.6M as it advances IMVT-1402. Cash stands at $797.8M, providing runway into 2027. The company reiterated topline data for IMVT-1402 in difficult-to-treat rheumatoid arthritis and cutaneous lupus is expected in H2 2026, with registrational trials in Graves' disease and myasthenia gravis starting in 2027. The stock is up 54.5% year-to-date, trading near its 52-week high, reflecting optimism around the upcoming data readouts. This follows strong preliminary Phase 2b results in May that drove a significant rally.

At the time of this announcement, IMVT was trading at $39.74 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $8.2B. The 52-week trading range was $14.32 to $41.23. This news item was assessed with neutral market sentiment and an importance score of 7 out of 10. Source: Wiseek News.


Price Chart

Share this article

Copied!

IMVT - Latest Insights

IMVT
Nov 09, 2026, 7:20 AM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $35.20
Real-time Price: $33.31 info
Change: -$1.90 (-5%) info
Market Cap: $6.893B info
IMVT
Nov 09, 2026, 7:09 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $35.85
Real-time Price: $33.31 info
Change: -$2.55 (-7%) info
Market Cap: $6.893B info
IMVT
Nov 09, 2026, 7:01 AM EST
Source: Reuters
Importance Score:
7
Price at Filing: $28.10
Real-time Price: $33.31 info
Change: +$5.20 (+19%) info
Market Cap: $6.893B info
IMVT
Nov 09, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $28.10
Real-time Price: $33.31 info
Change: +$5.20 (+19%) info
Market Cap: $6.893B info
IMVT
Sep 23, 2026, 7:01 AM EDT
Source: Reuters
Importance Score:
9
Price at Filing: $36.20
Real-time Price: $33.31 info
Change: -$2.90 (-8%) info
Market Cap: $6.893B info